Effect of aluminum phosphate gel on prevention of early rebleeding after ligation of esophageal variceal hemorrhage

Table 1 Baseline data of the two groups

Characteristic	PPI group (n = 401)	PPI + APG group (n = 377)	P value
Age (yr)	53.55 ± 12.55	52.73 ± 13.35	0.376
Female/Male	83/318	73/304	0.642
MELD score	14.94 ± 3.05	15.19 ± 3.30	0.275
Prothrombin activity (%)	65.30 ± 15.26	65.70 ± 16.94	0.731
Fibrinogen (g/dL)	1.94 ± 0.68	2.00 ± 0.73	0.211
Platelet (109/L)	104.43 ± 69.88	97.67 ± 70.20	0.179
Albumin (g/dL)	3.39 ± 0.51	3.40 ± 0.52	0.682
Hemoglobin (g/dL)	8.92 ± 0.68	8.86 ± 0.69	0.229

PPI: Proton pump inhibitor; APG: Aluminum phosphate gel; MELD: Model for end-stage liver disease.